Navigation Links
Meritage Pharma Initiates Phase 2b Clinical Trial of Oral Viscous Budesonide for Pediatric Patients With Eosinophilic Esophagitis
Date:1/22/2009

SAN DIEGO, Jan. 22 /PRNewswire/ -- Meritage Pharma, Inc. announced today that it has initiated a dose-ranging Phase 2b clinical trial to evaluate oral viscous budesonide (OVB) for the treatment of children and adolescents with eosinophilic esophagitis (EoE), an allergic inflammatory condition of the esophagus. EoE can cause difficulty in swallowing and heartburn, and in severe cases it can lead to food impaction (food getting stuck in the esophagus) and in children, a failure to thrive (poor growth or weight loss). The trial is being conducted at multiple U.S. clinical centers that specialize in the treatment of patients with gastrointestinal diseases.

EoE is an emerging disease that has only recently been classified as a separate condition. Most centers of excellence have seen a dramatic rise in the incidence and diagnosis of EoE over the last decade. EoE tends to be a chronic disease with persistent or relapsing symptoms. The disease occurs when eosinophils, a type of white blood cell involved in allergic reactions, infiltrate the surface of the esophagus. This eosinophil infiltration leads to inflammation of the esophagus and is believed to cause the symptoms of EoE. A variety of stimuli may trigger this allergic process including certain foods and environmental allergens. People with EoE commonly have other allergic conditions such as asthma or eczema.

Symptoms of EoE may include nausea, dysphagia (problems swallowing), vomiting, stomach pain, chest pain, heartburn, loss of weight, and food impaction. Other symptoms may include reflux that does not respond to proton pump inhibitor therapy, failure to thrive, poor appetite, malnutrition and difficulty sleeping.

The double-blind, randomized, placebo-controlled 12-week study in up to 80 patients with confirmed EoE aged two to 18 is designed to evaluate three different doses of OVB. Patients will be evaluated by performing biopsies of the esophagus obtain
'/>"/>

SOURCE Meritage Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium
2. ISTA Pharmaceuticals New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration
3. Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
4. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
5. Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
6. Solace Pharmaceuticals Initiates Phase IIa Trial of Glial Cell Modulator SLC022 in Post-Herpetic Neuralgia
7. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
8. Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2
9. Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009
10. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
11. Pharmasset Reports Fiscal Year End 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 Research and Markets has ... - Forecasts to 2019" report to their offering. ... estimated to grow at a lower CAGR in developed countries; however, ... as China , India , ... The growth of the hematology analyzers and reagents market ...
(Date:7/30/2014)...  Today the US Surgeon General issued the most stern ... sun burns stating they can lead directly to deadly melanoma ... , says that "skin cancer is a major public health ... to indoor and outdoor ultraviolet light is a major cause." ... Boca Raton, Florida , Marta I. ...
(Date:7/30/2014)... , July 30, 2014 /PRNewswire-iReach/ -- Transluminal ... -based medical device company, has announced today that ... velox CD™ Vascular Closure Device. Velox CD™ provides ... hemostasis following percutaneous femoral procedures. The single size ... ranging in size from 5F to 8F.  ...
Breaking Medicine Technology:Hematology Analyzers & Reagents Market - Forecasts to 2019 2Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device 2
... Patients on corticosteroids are one-third less likely to ... taking statin medicationsStudy is first in a series ... medicationsFRANKLIN LAKES, N.J., March 14 Results of ... Meeting of the American Academy of Asthma, Allergy ...
... YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, ... and commercializes differentiated products for patients worldwide, ... properties of the anti-EGFR monoclonal antibody, nimotuzumab, ... and epidermal cells", has been accepted for ...
Cached Medicine Technology:New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 2New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 3New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 4YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 3YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 4YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 5
(Date:7/30/2014)... July 30, 2014 Shabaikai is an ... forests of the Pomo Indians located on the shores ... the river Shabaikai, meaning ‘crooked snake’. Clarkson takes the ... and the violence of prohibition and organized crime, providing ... River. Here, the most powerful men in the world ...
(Date:7/30/2014)... Antonio, TX (PRWEB) July 30, 2014 ... with Christus Spohn Health, recently announced the proposed naming ... TX: the Dr. Hector P. Garcia Family Health Center. ... state-of-the-art primary health care services, including comprehensive chronic disease ... It will also be a pioneering medical home model ...
(Date:7/30/2014)... July 30, 2014 Naomi Fried, ... the Board of Directors of the American Telemedicine ... the Association, which has a mission to promote ... through telecommunications and information technology. , “Both Naomi ... Association, possess extraordinary expertise and are well known ...
(Date:7/30/2014)... have identified a protein that could help doctors decide ... that makes radiotherapy more effective, according to a study* ... (BJC). , The team from The University of Manchester, ... whose bladder tumour had high levels of a protein, ... carbogen oxygen mixed with carbon dioxide gas ...
(Date:7/30/2014)... Rhode Island Hospital researchers have found that a ... reduce depression and other symptoms in informal caregivers, ... dementia. The study is published online in advance ... Dementia . , "Those caring for people with ... often under a great deal of pressure," said ...
Breaking Medicine News(10 mins):Health News:Bill E. Clarkson Releases Debut Fact-Based Novel, Shabaikai 2Health News:Dr. Hector P Garcia Memorial Foundation Supports New Health Care Facility 2Health News:American Telemedicine Association Welcomes Two New Members to the Board of Directors 2Health News:Scientists pinpoint bladder cancer patients who could benefit from 'tumor-softening' treatment 2Health News:Study: Telephone support program beneficial for caregivers of those with dementia 2
... A paper by Indiana University-Purdue University Indianapolis ... to improve identification of breast cancer tissue by ... scientific paper in the "bioinformatics and biomedical applications ... The best scientific paper award ...
... "fused" with a groupa bond even stronger than group identificationwill ... outsiders, conclude researchers in a new study published in ... Science. This intense bond to a group may help explain ... B. Swann, Jr., of the University of Texas, came up ...
... and adolescents have become fatter over the last ... Bloomberg School of Public Health and National Institute ... across socio-demographic groups over time and found U.S. ... such as body mass index (BMI), waist circumference ...
... and women in the Troms Study in northern Norway has reported ... cognitive tests. The subjects (average age 58 and free of ... with a range of cognitive function tests. Among women, there was ... consumed wine at least 4 or more times over two ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, Aug. ... of imaging to guide the needle now make up the majority ... the use of these minimally invasive biopsies increased from 59 percent ... trend which is likely to continue, one expert noted. A biopsy ...
... (CLASS) Act a largely overlooked component of the 2010 ... to transform long-term care financing in the United States from ... issue of Public Policy & Aging Report ... SCAN Foundation , this installment of PPAR features ...
Cached Medicine News:Health News:People with 'fused' identities are willing to die for their social group 2Health News:Overweight American children and adolescents becoming fatter 2Health News:Moderate drinking, especially wine, associated with better cognitive function 2Health News:Less Invasive Biopsies Gain Favor 2Health News:CLASS Act analysis reveals America's long-term care future 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: